This manuscript describes a sensitive, selective, and online in-tube solid-phase microextraction coupled with an ultrahigh performance liquid chromatography-tandem mass spectrometry (in-tube SPME-UHPLC-MS/MS) method to determine chlopromazine, clozapine, quetiapine, olanzapine, and their metabolites in plasma samples from schizophrenic patients. Organic poly(butyl methacrylate-co-ethylene glycol dimethacrylate) monolith was synthesized on the internal surface of a fused silica capillary (covalent bonds) for in-tube SPME. Analyte extraction and analysis was conducted by connecting the monolithic capillary to an UHPLC-MS/MS system. The monolith was characterized by scanning electron microscopy (SEM) and Fourier transform infrared spectrometry (FTIR). The developed method presented adequate linearity for all the target antipsychotics: R2 was higher than 0.9975, lack-of-fit ranged from 0.115 to 0.955, precision had variation coefficients lower than 14.2%, and accuracy had relative standard error values ranging from −13.5% to 14.6%, with the exception of the lower limit of quantification (LLOQ). The LLOQ values in plasma samples were 10 ng mL−1 for all analytes. The developed method was successfully applied to determine antipsychotics and their metabolites in plasma samples from schizophrenic patients.
这篇手稿描述了一种敏感、选择性和在线管内固相微萃取结合超高效液相色谱-串联质谱(管内SPME-UHPLC-MS/MS)方法,用于测定精神分裂症患者血浆样本中氯丙嗪、氯氮平、奎硫平、奥氮平及其代谢物的含量。有机聚合物(丁基甲基丙烯酸酯-乙二醇二甲基丙烯酸酯共聚物)单体在熔融二氧化硅毛细管的内表面上合成(共价键),用于管内SPME。通过将单体毛细管连接到UHPLC-MS/MS系统进行样品提取和分析。单体通过扫描电子显微镜(SEM)和傅里叶变换红外光谱仪(FTIR)进行表征。开发的方法对所有目标抗精神病药物均具有适当的线性关系:R2高于0.9975,缺乏拟合范围为0.115至0.955,精密度的变异系数低于14.2%,准确度的相对标准误差值范围为-13.5%至14.6%,除了定量下限(LLOQ)。血浆样本中的LLOQ值为10 ng mL−1。该方法成功应用于测定精神分裂症患者血浆样本中的抗精神病药物及其代谢物。